Today's +1% Nifty print looks better than it is. The index is still below its 200-day average, 8.1% off its 52-week high, and the six-session continuity series shows no decisive trend — just a sharp down day on 8 July followed by two days of recovery. This is a bounce inside a range, not the start of a fresh advance.
Trajectory: recovery, not resolution
The fast short-term breadth gauge — the share of stocks above their 20-day average — collapsed from 61% on 3 July to 35% on 8 July as the index dropped 2.1%, then clawed back to 50% today. That is a two-day snap-back, not a trend. The slow structural gauge, the share above their 200-day average, tells the same story: it slid from 44% to 39% during the sell-off and has only recovered to 43% — barely back to where it started the week. Advancers led decliners 1,599 to 613 today and net new highs came in at 141, both solid on the surface, but on 6 July advancers actually lost to decliners 929 to 1,288 even as the index rose 0.7% — a warning the index was being carried by a thin top. Until the fast breadth gauge sustains above 55% and net new highs stop oscillating between negative and 140, this tape is range-bound and the setups that clear the screen will face a tougher follow-through environment than the day's headline suggests.
Leadership: Real Estate and Health Care doing the work
Real Estate led on the day at +3.1% and is the only sector with consistent leadership across the one-month and three-month rankings — up 22% and 25% respectively. Information Technology added 1.8% today but remains a three-month laggard at -2.3%, so today's move deserves scepticism. The Stage-2 cohort is expanding fastest in Health Care, Consumer Discretionary and Financials, and it is in Health Care where the screen is producing its cleanest names — IND Swift Laboratories, which has been in Stage 2 for five weeks, cleared the screen with the sector's structural momentum behind it. The net flow of 47 stocks moving from Stage 1 into Stage 2 against 30 going the other way over the last five days is a mild positive, but with the structural breadth gauge still only at 43%, the advancing cohort is widening from a low base.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Aurum Proptech Ltd | Information Technology | 9.4 | +2.8% |
| Fusion Finance Ltd | Financials | 9.4 | +2.1% |
| S.P.Apparels Ltd | Consumer Discretionary | 9.4 | -1.6% |
| Lokesh Machines Ltd | Industrials | 9.4 | -2.0% |
| Tirupati Forge Ltd | Consumer Discretionary | 9.4 | +1.5% |
| IND Swift Laboratories Ltd | Health Care | 9.2 | +4.6% |
| Venus Pipes and Tubes Ltd | Materials | 9.0 | +0.3% |
| Beta Drugs Ltd | Health Care | 9.0 | +8.1% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Real Estate | +3.1% | +22.1% | +25.2% | 54 | 22% |
| Information Technology | +1.8% | +0.9% | -2.3% | 35 | 28% |
| Energy | +1.7% | +4.2% | -1.0% | 54 | 39% |
| Financials | +1.6% | +7.9% | +3.3% | 61 | 35% |
| Utilities | +1.6% | +1.2% | +17.7% | 63 | 30% |
| Materials | +1.4% | +2.0% | +7.4% | 67 | 38% |
| Industrials | +1.3% | +5.2% | +20.0% | 68 | 39% |
| Consumer Discretionary | +0.8% | +7.4% | +8.4% | 66 | 35% |
| Health Care | +0.4% | +7.1% | +20.7% | 73 | 50% |
| Consumer Staples | +0.1% | +1.8% | +6.8% | 56 | 33% |
| Communication Services | +0.1% | +9.3% | +14.2% | 61 | 18% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.